These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 17953518

  • 1. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC, de Graaf J, van Greevenbroek MM, Georgieva AM, van der Kallen CJ, Ter Avest E, Stehouwer CD, Stalenhoef AF, de Bruin TW.
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [Abstract] [Full Text] [Related]

  • 2. Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study.
    Brouwers MC, Dekker JM, van Greevenbroek MM, van der Kallen CJ, Heine RJ, de Bruin TW, Stehouwer CD.
    Diabet Med; 2008 Sep; 25(9):1121-4. PubMed ID: 19183319
    [Abstract] [Full Text] [Related]

  • 3. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF, McGladdery SH, McNeely MJ, Austin MA, Motulsky AG, Brunzell JD.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1289-94. PubMed ID: 12750118
    [Abstract] [Full Text] [Related]

  • 4. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E, Sniderman AD, Bredie SJ, Wiegman A, Stalenhoef AF, de Graaf J.
    Clin Sci (Lond); 2007 Jan 01; 112(2):131-9. PubMed ID: 17054424
    [Abstract] [Full Text] [Related]

  • 5. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC, van Greevenbroek MM, Vermeulen VM, van Lin JM, van der Kallen CJ, de Bruin TW.
    Clin Sci (Lond); 2007 Nov 01; 113(9):375-81. PubMed ID: 17564583
    [Abstract] [Full Text] [Related]

  • 6. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
    Veerkamp MJ, de Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF.
    Circulation; 2004 Jun 22; 109(24):2980-5. PubMed ID: 15184285
    [Abstract] [Full Text] [Related]

  • 7. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW.
    Arterioscler Thromb Vasc Biol; 2004 Apr 22; 24(4):744-9. PubMed ID: 14751815
    [Abstract] [Full Text] [Related]

  • 8. Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein ε2.
    Brouwers MC, van Greevenbroek MM, Konrad RJ, Troutt JS, Schaper NC, Stehouwer CD.
    Clin Sci (Lond); 2014 May 22; 126(9):679-84. PubMed ID: 24308640
    [Abstract] [Full Text] [Related]

  • 9. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP.
    Expert Opin Ther Targets; 2009 Jul 22; 13(7):743-51. PubMed ID: 19505224
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 22; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR.
    Arteriosclerosis; 1989 Jan 22; 9(3):335-44. PubMed ID: 2497719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
    Sziegoleit W, Wichmann T, Block HU, Taube C, Mest HJ.
    Wien Klin Wochenschr; 1991 Jan 22; 103(8):227-31. PubMed ID: 1858388
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.
    Pauciullo P, Gentile M, Marotta G, Baiano A, Ubaldi S, Jossa F, Iannuzzo G, Faccenda F, Panico S, Rubba P.
    Atherosclerosis; 2009 Mar 22; 203(1):320-4. PubMed ID: 18760784
    [Abstract] [Full Text] [Related]

  • 19. Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
    Vakkilainen J, Pajukanta P, Cantor RM, Nuotio IO, Lahdenperä S, Ylitalo K, Pihlajamäki J, Kovanen PT, Laakso M, Viikari JS, Peltonen L, Taskinen MR.
    Eur J Hum Genet; 2002 Sep 22; 10(9):547-52. PubMed ID: 12173032
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.